levodopa has been researched along with trihexyphenidyl in 86 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 44 (51.16) | 18.7374 |
1990's | 24 (27.91) | 18.2507 |
2000's | 11 (12.79) | 29.6817 |
2010's | 4 (4.65) | 24.3611 |
2020's | 3 (3.49) | 2.80 |
Authors | Studies |
---|---|
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Greer, M | 1 |
Ringwald, E | 1 |
Lörincz, P; Ludin, HP; Ringwald, E | 1 |
Barbeau, A; Butterworth, RF; Campanella, G; Yamada, K | 1 |
Taylor, J | 1 |
Bedard, P; Marsden, CD; Parkes, JD | 1 |
Hökendorf, H | 1 |
Mace, M; Rawlins, MD | 1 |
Adamkov, J; Drobný, M; Fundárek, J; Svaleková, A | 1 |
Barthal, JS; Garrett, G; Schultz, DR | 1 |
Agnoli, A; Denaro, A; Lelli, A; Ruggieri, S | 1 |
Marsden, CD; Mindham, RH; Parkes, JD | 1 |
Marsden, CD | 1 |
Kunz, F; Lörincz, P; Ludin, HP; Ringwald, E | 1 |
Lukasiewicz, K | 1 |
Audouin, J; Bilski Pasquier, G; Dao, C; Diebold, J; James, JM; Mignot, L; Reynes, M; Tricot, G | 1 |
Allen, N; Knopp, W | 1 |
Bianchine, JR | 1 |
Evtushenko, SK | 1 |
Ohtomo, E | 1 |
Bergen, D; Goetz, C; Klawans, HL | 1 |
Barnett, A; Goldstein, J | 1 |
Barnett, A; Goldstein, JM; Malick, JB | 1 |
Algeri, S; Bonollo, L; Buniva, G; Cerletti, C; Curcio, M; Minazzi, M; Minoli, G; Morselli, PL | 1 |
Stimmel, GL | 1 |
Parkenberg, H | 1 |
Asanuma, M; Chou, H; Hirata, H; Mori, A; Ogawa, N | 1 |
Fredow, G; Löscher, W | 1 |
Suitsu, N | 1 |
Cooper, JA; Jordan, N; Sagar, HJ | 1 |
Nakashima, K; Takahashi, K | 1 |
Onodera, K; Shinoda, H | 1 |
Downes, JJ; Evenden, JL; Morris, RG; Robbins, TW; Roberts, AC; Sahakian, BJ | 1 |
Hardie, RJ; Lees, AJ | 1 |
Kurahashi, K; Matsunaga, M; Narita, S; Tanaka, T; Watahiki, Y | 1 |
Godlevskiĭ, LS; Kryzhanovskiĭ, GN; Makul'kin, RF; Rozhkov, VS; Shandra, AA | 1 |
Herbster, G; Koller, WC | 1 |
Koller, WC | 1 |
Ando, K; Mano, Y; Satoyoshi, E; Sunohara, N | 1 |
Koller, WC; Rubino, FA | 1 |
Jankovic, J; Pettigrew, LC | 1 |
Barone, G; Carotti, A; Lucciarini, L; Mugnai, A; Tomassetti, G | 1 |
Muenter, MD; Sharpless, NS; Tyce, GM | 1 |
Harrison, MJ; Marsden, CD | 1 |
Baker, AB; Loewenson, RB; Martin, WE; Resch, JA | 1 |
Luther, JS; Stoudemire, A | 1 |
Alonso, RJ; Covington, TR; Mancall, EL | 1 |
Honda, Y; Kagono, Y; Kita, S; Saito, M; Suitsu, N | 1 |
Kojima, T; Shiozaki, Z; Shuto, K; Tanaka, M | 1 |
Caviglia, A; Cellitti, M; Di Bianco, V; Di Castro, A; Pavoncello, S | 1 |
Kawai, H; Mitsui, T; Miyata, M; Saito, S; Sakoda, S | 1 |
Linazasoro, G | 1 |
Hineno, T; Horiguchi, J; Kakimoto, Y; Mizobuchi, M; Nishimatsu, O | 1 |
Kurisaki, H; Mizuno, T | 1 |
Akiguchi, I; Nakamura, S | 1 |
Hirose, K; Isozaki, E; Miyamoto, K; Noda, K; Oda, M; Tanabe, H | 1 |
Gorchein, A | 1 |
Asahina, M; Hirayama, K; Inoue, O; Shinotoh, H; Suhara, T; Tateno, Y | 1 |
Felice, KJ; Grunnet, ML | 1 |
Kishore, A; Snow, BJ | 1 |
Bulling, M; Macklin, BS; O'Shea, N; Roberts, J; von Renwick, AG; Waller, DG | 1 |
Bowes, SG; Charlett, A; Dobbs, RJ; Dobbs, SM; Hunt, WB; Kirollos, C; Kosik, R; Mozol, K; Nicholson, PW; O'Neill, CJ; Purkiss, AG; Weller, C | 1 |
de Saint-Martin, A; Hirsch, E; Marescaux, C; Picard, F; Salmon, E | 1 |
Gerritsen, JJ; Lammers, GJ; Meinders, AE; Roos, RA; van Laar, T | 1 |
Domino, EF; Ni, L | 1 |
Ebinger, G; Izurieta-Sánchez, P; Michotte, Y; Sarre, S | 2 |
Agid, Y; Bédard, MA; Dubois, B; Duchesne, N; Masson, H; Pillon, B | 1 |
Barbero-Aguirre, P | 1 |
Hattori, T; Sakakibara, R; Uchiyama, T; Yoshiyama, M | 1 |
Kuroiwa, Y; Momose, T; Okada, M; Yamada, H | 1 |
Kachi, T | 1 |
Okamoto, K; Tanaka, M | 1 |
Kishore, D; Misra, S; Singh, NN; Verma, R | 1 |
Hattori, N | 1 |
Hachimori, K; Hayashi, M; Kimura, K; Nagao, Y; Nomura, Y; Segawa, M | 1 |
Pal, PK; Prashantha, DK | 1 |
Cao, HM; Guo, F; Qiao, J; Qu, QM; Wang, RL; Zhe, X | 1 |
Hashim, HZ; Ibrahim, N; Ngiu, CS; Tan, HJ; Wan Musa, WR; Wan Yahya, WN | 1 |
Camargos, S; Cardoso, F; Lees, AJ; Singleton, A | 1 |
Lalla, R; Patil, TB; Verma, R | 1 |
Kaminska, M; Lin, JP; Lumsden, DE; Tomlin, S | 1 |
Choi, JH; Jeon, B; Kim, HJ; Kim, R; Park, S; Shin, J; Woo, KA; Yoo, D | 1 |
Batra, D; Bhattacharya, A; Holla, VV; Kamble, N; Pal, PK; Prasad, S; Sahoo, LK; Yadav, R | 1 |
Bohn, E; Falck-Ytter, Y; Fehlings, D; Goren, K; Switzer, L | 1 |
8 review(s) available for levodopa and trihexyphenidyl
Article | Year |
---|---|
Advances in the management of parkinson's disease.
Topics: Amantadine; Anesthesia; Humans; Levodopa; Orphenadrine; Parasympatholytics; Parkinson Disease; Social Adjustment; Trihexyphenidyl | 1976 |
[Oral dyskinesis, facial dystonia].
Topics: Dyskinesia, Drug-Induced; Dystonia; Face; Female; Humans; Levodopa; Male; Meige Syndrome; Mouth; Movement Disorders; Receptors, Dopamine D1; Sulpiride; Tiapamil Hydrochloride; Trihexyphenidyl | 1993 |
Drug management of Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Selegiline; Trihexyphenidyl | 1996 |
[Disturbance of micturition in Parkinson's disease].
Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reflex, Abnormal; Trihexyphenidyl; Urinary Bladder, Neurogenic; Urination; Urination Disorders; Urodynamics | 2001 |
[Medical treatment of dystonia].
Topics: Cholinergic Antagonists; Clonazepam; Diazepam; Dopamine Antagonists; Dystonia; Humans; Levodopa; Torticollis; Trihexyphenidyl | 2001 |
[Neuromuscular disorders due to adverse effects of antiparkinson agents].
Topics: Amantadine; Antiparkinson Agents; Catechols; Dopamine Agonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuromuscular Diseases; Nitriles; Trihexyphenidyl | 2007 |
Patient-reported responses to medical treatment in primary dystonia.
Topics: Baclofen; Benzodiazepines; Dystonic Disorders; Female; Humans; Levodopa; Male; Medical Records; Patient Reported Outcome Measures; Treatment Outcome; Trihexyphenidyl | 2020 |
Pharmacological and neurosurgical interventions for individuals with cerebral palsy and dystonia: a systematic review update and meta-analysis.
Topics: Baclofen; Botulinum Toxins; Cerebral Palsy; Clonidine; Deep Brain Stimulation; Dystonia; Humans; Injections, Spinal; Levodopa; Neurosurgical Procedures; Trihexyphenidyl | 2021 |
11 trial(s) available for levodopa and trihexyphenidyl
Article | Year |
---|---|
[Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
Topics: Antipsychotic Agents; Bromocriptine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Humans; Levodopa; Receptors, Dopamine; Schizophrenia; Time Factors; Trihexyphenidyl | 1978 |
Bromocriptine in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Piperidines; Thioxanthenes; Trihexyphenidyl | 1978 |
Nomifensine in Parkinson's disease.
Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Isoquinolines; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Placebos; Trihexyphenidyl | 1977 |
Psychiatric symptoms during l-dopa therapy for Parkinson's disease and their relationship to physical disability.
Topics: Aged; Amantadine; Carbidopa; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Interview, Psychological; Levodopa; Male; Mental Status Schedule; Methyldopa; Middle Aged; Parkinson Disease; Placebos; Recurrence; Trihexyphenidyl | 1976 |
[Clinical experience with bromocriptine, a central dopaminergic stimulator].
Topics: Aged; Amantadine; Bromocriptine; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Trihexyphenidyl | 1976 |
[A computer-assisted EEG study on psychotropic properties of antiparkinsonian drugs].
Topics: Amantadine; Antiparkinson Agents; Biperiden; Bromocriptine; Electroencephalography; Glycolates; Humans; Levodopa; Male; Psychotropic Drugs; Thiophenes; Trihexyphenidyl | 1992 |
Adjuvant therapy of parkinsonian tremor.
Topics: Aged; Antiparkinson Agents; Carbidopa; Clonazepam; Double-Blind Method; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Primidone; Propranolol; Random Allocation; Tremor; Trihexyphenidyl | 1987 |
A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease.
Topics: Affective Symptoms; Aged; Anxiety; Clinical Trials as Topic; Confusion; Drug Evaluation; Drug Therapy, Combination; Female; Hallucinations; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Placebos; Sleep Wake Disorders; Time Factors; Trihexyphenidyl; Vomiting | 1974 |
The effects of co-administration of benzhexol on the peripheral pharmacokinetics of oral levodopa in young volunteers.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Antiparkinson Agents; Chelating Agents; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Gastric Emptying; Humans; Levodopa; Male; Muscarinic Antagonists; Pentetic Acid; Trihexyphenidyl | 1996 |
Objective measurement of activation of rigidity: diagnostic, pathogenetic and therapeutic implications in parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Hand Strength; Humans; Isometric Contraction; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Physical Exertion; Reproducibility of Results; Sensitivity and Specificity; Torque; Trihexyphenidyl | 1996 |
Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome.
Topics: Acute Disease; Cholinergic Antagonists; Cognition Disorders; Corpus Striatum; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Levodopa; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Parkinson Disease; Scopolamine; Severity of Illness Index; Substantia Nigra; Syndrome; Time Factors; Trihexyphenidyl | 1999 |
67 other study(ies) available for levodopa and trihexyphenidyl
Article | Year |
---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
How to achieve maximum benefit for the patient with Parkinson's disease.
Topics: Aged; Amantadine; Carbidopa; Diagnosis, Differential; Histamine H1 Antagonists; Humans; Levodopa; Nervous System Diseases; Occupational Therapy; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Psychotherapy; Trihexyphenidyl | 1976 |
Uptake and efflux of 14-C-dopamine in platelets: evidence for a generalized defect in Parkinson's disease.
Topics: Adult; Aged; Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Blood Platelets; Carbon Radioisotopes; Depression, Chemical; Dopamine; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Female; Histamine H1 Antagonists; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Time Factors; Trihexyphenidyl | 1975 |
Parkinson's disease.
Topics: Amantadine; Benztropine; Humans; Levodopa; Parkinson Disease; Procyclidine; Trihexyphenidyl | 1977 |
Combination therapy of extrapyramidal disease with trihexyphenidyl and L-dopa: an electromyographic study with specific reference to tremor.
Topics: Aged; Basal Ganglia Diseases; Drug Therapy, Combination; Electromyography; Female; Humans; Levodopa; Middle Aged; Parkinson Disease; Torticollis; Tremor; Trihexyphenidyl | 1979 |
Parkinson's disease.
Topics: Aged; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Male; Parkinson Disease; Trihexyphenidyl | 1979 |
[Therapy of rigidity and hypokinesis in old age using Sinemet].
Topics: Aged; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Movement Disorders; Muscle Rigidity; Parkinson Disease, Postencephalitic; Trihexyphenidyl | 1979 |
Western equine encephalitis with rapid onset of parkinsonism.
Topics: Adult; Carbidopa; Encephalitis Virus, Western Equine; Encephalomyelitis, Equine; Female; Humans; Levodopa; Parkinson Disease; Trihexyphenidyl | 1977 |
Parkinson's disease improvement after the addition of levodopa-carbidopa to anticholinergic treatment. An open controlled study.
Topics: Administration, Oral; Adult; Aged; Carbidopa; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease, Secondary; Tremor; Trihexyphenidyl | 1978 |
[Combined treatment of parkinsonism with L-dopa and Parkopan].
Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Trihexyphenidyl | 1977 |
[Immunoblastic lymphoid hyperplasia resembling a tumour, due to drug hypersensitivity (author's transl)].
Topics: Blood Protein Disorders; Blood Vessels; Drug Hypersensitivity; Humans; Hyperplasia; Levodopa; Lymphadenitis; Male; Middle Aged; Trihexyphenidyl | 1976 |
Hereditary Parkinsonism-dystonia with sustained control by L-DOPA and anticholinergic medication.
Topics: Adolescent; Adult; Aged; Dopamine beta-Hydroxylase; Dystonia Musculorum Deformans; Female; Growth Hormone; Handwriting; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Parkinson Disease; Pedigree; Prolactin; Reflex, Pupillary; Syndrome; Trihexyphenidyl | 1976 |
Drug therapy of parkinsonism.
Topics: Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior; Dopa Decarboxylase; Drug Interactions; Humans; Levodopa; Parkinson Disease; Trihexyphenidyl | 1976 |
[Combined treatment of Parkinsonism with levopa, midantan and anticholinergic drugs].
Topics: Acetylcholine; Adult; Aged; Amantadine; Antiparkinson Agents; Cholinesterases; Drug Therapy, Combination; Female; Humans; Intracranial Arteriosclerosis; Levodopa; Male; Middle Aged; Muscle Tonus; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary; Trihexyphenidyl | 1976 |
[Oral dyskinesia (author's transl)].
Topics: Aged; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Masticatory Muscles; Movement Disorders; Tongue Habits; Trihexyphenidyl | 1976 |
Levodopa-induced myoclonus.
Topics: 5-Hydroxytryptophan; Aged; Amantadine; Amphetamine; Animals; Benztropine; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Guinea Pigs; Humans; Levodopa; Male; Methysergide; Middle Aged; Movement Disorders; Myoclonus; Parkinson Disease; Propranolol; Serotonin; Serotonin Antagonists; Sleep; Trihexyphenidyl | 1975 |
Head-turning induced by electrical stimulation of the caudate nucleus and its antagonism by anti-parkinson drugs.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Benztropine; Caudate Nucleus; Depression, Chemical; Electric Stimulation; Humans; Levodopa; Male; Rats; Stereotyped Behavior; Trihexyphenidyl | 1975 |
The evaluation of anti-parkinson drugs on reserpine-induced rigidity in rats.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Benztropine; Carbidopa; Hindlimb; Levodopa; Male; Methamphetamine; Muscle Rigidity; Rats; Reserpine; Scopolamine; Time Factors; Trihexyphenidyl | 1975 |
Effect of anticholinergic drugs on gastro-intestinal absorption of L-dopa in rats and in man.
Topics: Administration, Oral; Adult; Aged; Animals; Atropine; Digestive System; Drug Interactions; Female; Humans; Injections, Intraperitoneal; Intestinal Absorption; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Rats; Time Factors; Trihexyphenidyl | 1976 |
Neuroleptics and the corpus striatum: clinical implications.
Topics: Acetylcholine; Basal Ganglia Diseases; Benztropine; Corpus Striatum; Dopamine; Fluphenazine; Haloperidol; Humans; Levodopa; Models, Neurological; Movement Disorders; Parkinson Disease; Reserpine; Schizophrenia; Tranquilizing Agents; Trihexyphenidyl | 1976 |
[Treatment of parkinsonism].
Topics: Amantadine; Benztropine; Biperiden; Humans; Levodopa; Orphenadrine; Parkinson Disease; Procyclidine; Trihexyphenidyl | 1976 |
Muscarinic cholinergic receptor-mediated modulation on striatal c-fos mRNA expression induced by levodopa in rat brain.
Topics: Actins; Animals; Blotting, Northern; Carbachol; Corpus Striatum; Gene Expression; Genes, fos; Levodopa; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Muscarinic; RNA, Messenger; Trihexyphenidyl | 1992 |
Effects of pharmacological manipulation of dopaminergic and cholinergic neurotransmission in genetically dystonic hamsters.
Topics: Acetylcholine; Animals; Apomorphine; Behavior, Animal; Carbidopa; Cricetinae; Dopamine; Drug Interactions; Dystonia; Haloperidol; Levodopa; Mesocricetus; Motor Activity; Mutation; Pilocarpine; Synaptic Transmission; Trihexyphenidyl | 1992 |
A component analysis of the generation and release of isometric force in Parkinson's disease.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isometric Contraction; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Neurons; Muscles; Neurologic Examination; Parkinson Disease; Reaction Time; Trihexyphenidyl | 1992 |
Exteroceptive suppression of the masseter and temporalis muscles and parkinsonian rigidity.
Topics: Adult; Aged; Amantadine; Basal Ganglia; Bromocriptine; Electric Stimulation; Electromyography; Female; Humans; Levodopa; Male; Masseter Muscle; Middle Aged; Muscle Rigidity; Muscle Spindles; Parkinson Disease; Temporal Muscle; Trigeminal Nerve; Trihexyphenidyl | 1991 |
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Neurons; Promethazine; Receptors, Muscarinic; Scopolamine; Trihexyphenidyl | 1991 |
Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction.
Topics: Aged; Attention; Drug Therapy, Combination; Female; Form Perception; Humans; Levodopa; Male; Middle Aged; Neurocognitive Disorders; Neuropsychological Tests; Parkinson Disease; Pattern Recognition, Visual; Psychomotor Performance; Reaction Time; Trihexyphenidyl | 1989 |
Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.
Topics: Adult; Aged; Antipsychotic Agents; Benserazide; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Psychotic Disorders; Trihexyphenidyl | 1988 |
[Akinetic mutism from recurrent hydrocephalus: successful treatment with levodopa, bromocriptine and trihexyphenidyl].
Topics: Adult; Akinetic Mutism; Bromocriptine; Drug Therapy, Combination; Humans; Hydrocephalus; Levodopa; Male; Recurrence; Trihexyphenidyl | 1987 |
[Modelling of the parkinsonian syndrome by the administration of kainic acid into the caudate nucleus].
Topics: Animals; Caudate Nucleus; Disease Models, Animal; Drug Evaluation, Preclinical; Electrodes, Implanted; Electroencephalography; Female; Injections; Kainic Acid; Levodopa; Male; Parkinson Disease, Secondary; Rats; Time Factors; Trihexyphenidyl | 1987 |
Pharmacologic treatment of parkinsonian tremor.
Topics: Amantadine; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tremor; Trihexyphenidyl | 1986 |
Idiopathic dystonia-parkinsonism with marked diurnal fluctuation of symptoms.
Topics: Adult; Bromocriptine; Electromyography; Electrophysiology; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Trihexyphenidyl | 1985 |
Combined resting-postural tremors.
Topics: Aged; Ethanol; Female; Humans; Levodopa; Male; Middle Aged; Posture; Propranolol; Rest; Tremor; Trihexyphenidyl | 1985 |
Hemidystonia: a report of 22 patients and a review of the literature.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Brain Damage, Chronic; Brain Diseases; Brain Injuries; Carbidopa; Child; Child, Preschool; Dominance, Cerebral; Dystonia; Dystonia Musculorum Deformans; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Tomography, X-Ray Computed; Trihexyphenidyl | 1985 |
[Trial use of L-dopa associated with a dopa-decarboxylase inhibitor in Parkinson's syndrome].
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Diphenhydramine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Histamine H1 Antagonists; Levodopa; Parasympatholytics; Parkinson Disease, Secondary; Trihexyphenidyl | 1974 |
3-O-Methyldopa in Parkinson's disease.
Topics: Antiparkinson Agents; Drug Antagonism; Drug Therapy, Combination; Humans; Levodopa; Methyldopa; Parkinson Disease; Time Factors; Trihexyphenidyl | 1974 |
Idiopathic torsion dystonia (dystonia musculorum deformans). A review of forty-two patients.
Topics: Adolescent; Adult; Child; Child, Preschool; Chlorpromazine; Diagnostic Errors; Diazepam; Disability Evaluation; Dystonia Musculorum Deformans; Female; Gait; Globus Pallidus; Humans; Infant; Levodopa; Male; Mental Disorders; Middle Aged; Perphenazine; Phenothiazines; Prognosis; Remission, Spontaneous; Tetrabenazine; Thalamus; Trihexyphenidyl | 1974 |
Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Carbidopa; Catatonia; Diagnosis, Differential; Female; Haloperidol; Humans; Levodopa; Syndrome; Trihexyphenidyl | 1984 |
Therapy of neurologic disorders in the elderly.
Topics: Aged; Amantadine; Anticoagulants; Brain Ischemia; Bromocriptine; Carbidopa; Dexamethasone; Drug Interactions; Heparin; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Trihexyphenidyl | 1984 |
Computerized EEG study on drug-induced extrapyramidalism in schizophrenic patients.
Topics: Adolescent; Amantadine; Brain; Computers; Electroencephalography; Female; Glycolates; Haloperidol; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Pyramidal Tracts; Reference Values; Schizophrenia; Thiophenes; Trihexyphenidyl | 1982 |
Antagonism of KW-5338 (domperidone) against emesis and depression of intestinal motility induced by L-DOPA.
Topics: Animals; Antiemetics; Dogs; Domperidone; Female; Gastrointestinal Motility; Levodopa; Male; Mice; Tremorine; Trihexyphenidyl | 1980 |
[Neurological aspects and modern trends in therapy of Parkinson's disease].
Topics: Atropine; Biperiden; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Procyclidine; Trihexyphenidyl | 1980 |
Hereditary parkinsonism with multiple system degeneration: beneficial effect of anticholinergics, but not of levodopa.
Topics: Adult; Amantadine; Basal Ganglia; Carbidopa; Cerebellar Ataxia; Cholinergic Antagonists; Consanguinity; Drug Resistance; Female; Genes, Recessive; Globus Pallidus; Homovanillic Acid; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinson Disease; Pedigree; Trihexyphenidyl | 1994 |
Anticholinergics and dyskinesia.
Topics: Aged; Biperiden; Carbidopa; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Tremor; Trihexyphenidyl | 1994 |
Day-night variation of urine volume in Parkinson's disease.
Topics: Adult; Aged; Amantadine; Bromocriptine; Circadian Rhythm; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors; Trihexyphenidyl; Urine | 1994 |
[A case of multiple system atrophy presenting a regular involuntary movement of the neck muscles synchronous with respiration].
Topics: Amantadine; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Muscular Atrophy; Neck Muscles; Respiration; Trihexyphenidyl | 1993 |
[Rhythmical involuntary movement at rest associated with olivo-ponto-cerebellar atrophy (OPCA)].
Topics: Adolescent; Aged; Brain; Clonazepam; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Olivopontocerebellar Atrophies; Parkinson Disease; Rest; Trihexyphenidyl | 1993 |
Treatment of Parkinson's disease in a patient with acute intermittent porphyria.
Topics: Aged; Antiparkinson Agents; Benserazide; Chlorpromazine; Dopamine Antagonists; Drug Interactions; Female; Humans; Levodopa; Parkinson Disease; Porphyria, Acute Intermittent; Trihexyphenidyl | 1995 |
Effects of trihexyphenidyl and L-dopa on brain muscarinic cholinergic receptor binding measured by positron emission tomography.
Topics: Aged; Binding, Competitive; Brain; Female; Humans; Kinetics; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Muscarinic; Tomography, Emission-Computed; Trihexyphenidyl | 1994 |
Inclusion body myositis associated with a severe unilateral levodopa-responsive upper extremity tremor.
Topics: Action Potentials; Anti-Dyskinesia Agents; Brain Neoplasms; Electromyography; Hand; Humans; Inclusion Bodies; Levodopa; Lipoma; Magnetic Resonance Imaging; Male; Microscopy, Electron; Middle Aged; Muscle, Skeletal; Myositis, Inclusion Body; Propranolol; Tremor; Trihexyphenidyl; Vacuoles | 1996 |
Postencephalitic stereotyped involuntary movements responsive to L-Dopa.
Topics: Adult; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Encephalitis; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinson Disease, Secondary; Putamen; Receptors, Dopamine D2; Stereotyped Behavior; Tomography, X-Ray Computed; Trihexyphenidyl | 1996 |
Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion.
Topics: Aged; Amantadine; Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Humans; Inappropriate ADH Syndrome; Levodopa; Longitudinal Studies; Male; Parkinson Disease; Trihexyphenidyl | 1998 |
Trihexyphenidyl potentiation of L-DOPA: reduced effectiveness three years later in MPTP-induced chronic hemiparkinsonian monkeys.
Topics: Animals; Antiparkinson Agents; Chronic Disease; Dopamine Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Female; Levodopa; Macaca nemestrina; MPTP Poisoning; Parkinson Disease, Secondary; Treatment Outcome; Trihexyphenidyl | 1998 |
Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of L-dopa in hemi-Parkinson rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Biotransformation; Corpus Striatum; Decarboxylation; Dopamine; Drug Interactions; Homovanillic Acid; Levodopa; Male; Microdialysis; Muscarinic Antagonists; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Substantia Nigra; Trihexyphenidyl | 1998 |
[Movement disorders: dystonias which are apparently psychosomatic. Torsion dystonias].
Topics: Antiparkinson Agents; Child; Diagnosis, Differential; Dystonia Musculorum Deformans; Humans; Levodopa; Male; Trihexyphenidyl | 1999 |
Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
Topics: Analysis of Variance; Animals; Corpus Striatum; Decarboxylation; Diamines; Dopamine; Extracellular Space; gamma-Aminobutyric Acid; Levodopa; Male; Microdialysis; Muscarinic Antagonists; Neurotransmitter Agents; Parasympatholytics; Perfusion; Pirenzepine; Rats; Rats, Wistar; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptors, Muscarinic; Substantia Nigra; Time Factors; Trihexyphenidyl | 2000 |
Anticholinergic drugs: response of parkinsonism not responsive to levodopa.
Topics: Adult; Brain Mapping; Cholinergic Antagonists; Corpus Striatum; Humans; Levodopa; Magnetic Resonance Imaging; Male; Neurons; Parkinsonian Disorders; Pyramidal Tracts; Substantia Nigra; Tomography, Emission-Computed; Trihexyphenidyl | 2002 |
[Therapy for patients with early-stage Parkinson's disease].
Topics: Amantadine; Animals; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Practice Guidelines as Topic; Selegiline; Trihexyphenidyl | 2003 |
Patient with limb girdle dystrophy presenting with dopa-responsive dystonia--a case report.
Topics: Adolescent; Dopamine Agents; Drug Therapy, Combination; Dystonia; Humans; Levodopa; Male; Muscular Dystrophies; Treatment Outcome; Trihexyphenidyl | 2003 |
[Case of DYT1 dystonia (early-onset torsion dystonia) showing long-term focal dystonia in the arm].
Topics: Child; Drug Therapy, Combination; Dystonia Musculorum Deformans; Female; Gene Deletion; Genes, Dominant; Humans; Levodopa; Molecular Chaperones; Treatment Outcome; Trihexyphenidyl | 2008 |
Serpentine tongue: A rare manifestation following initiation of levodopa therapy in a patient with Parkinson's disease.
Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tongue; Trihexyphenidyl | 2009 |
[The use of antiparkinsonism drugs in 92 cases in Xi'an city].
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; China; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Preference; Severity of Illness Index; Surveys and Questionnaires; Trihexyphenidyl | 2009 |
Parkinsonism complicating acute organophosphate insecticide poisoning.
Topics: Acute Disease; Adult; Antidotes; Antiparkinson Agents; Benserazide; Cholinesterase Inhibitors; Humans; Insecticides; Levodopa; Male; Organophosphate Poisoning; Parkinson Disease; Pralidoxime Compounds; Trihexyphenidyl | 2011 |
DYT16: the original cases.
Topics: Adolescent; Adult; Age of Onset; Anti-Dyskinesia Agents; Antiparkinson Agents; Baclofen; Biperiden; Botulinum Toxins; Carbidopa; Child; Child, Preschool; Cholinergic Antagonists; Drug Combinations; Drug Resistance; Dystonia; Dystonic Disorders; Female; Humans; Levodopa; Male; Middle Aged; Muscle Relaxants, Central; Mutation; Parkinsonian Disorders; Pedigree; Phenotype; RNA-Binding Proteins; Speech Disorders; Trihexyphenidyl; Young Adult | 2012 |
Is blinking of the eyes affected in extrapyramidal disorders? An interesting observation in a patient with Wilson disease.
Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Blinking; Carbidopa; Ceruloplasmin; Drug Therapy, Combination; Female; Hepatolenticular Degeneration; Humans; Levodopa; Penicillamine; Trihexyphenidyl; Zinc Sulfate | 2012 |
Medication use in childhood dystonia.
Topics: Adolescent; Antiparkinson Agents; Baclofen; Child; Chloral Hydrate; Cohort Studies; Diazepam; Drug-Related Side Effects and Adverse Reactions; Dystonia; Dystonic Disorders; Female; Humans; Hypnotics and Sedatives; Levodopa; Logistic Models; Male; Muscle Relaxants, Central; Risk Factors; Trihexyphenidyl | 2016 |
Comparison of effectiveness of trihexyphenidyl and levodopa on motor symptoms in Parkinson's disease.
Topics: Antiparkinson Agents; Humans; Hypokinesia; Infant, Newborn; Levodopa; Parkinson Disease; Treatment Outcome; Tremor; Trihexyphenidyl | 2020 |